2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-

Request For Quotation
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
CAS:2227368-54-7
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:JH-X-119-01
CAS:2227368-54-7
Purity:97.1% Package:1mg;60USD|2mg;88USD|5mg;147USD
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471;
Email: sales@sarms4muscle.com
Products Intro: Product Name:JH-X-119-01
CAS:2227368-54-7
Purity:99% Package:5KG;1KG Remarks:JH-X-119-01
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:JH-X-119-01
CAS:2227368-54-7
Purity:98% Package:5mg Remarks:V2464
Company Name: Nantong HI-FUTURE Biology Co., Ltd.
Tel: +undefined18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
CAS:2227368-54-7
Purity:98%+ HPLC Package:100MG,200MG,500MG,1G,5G,10G...

2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- manufacturers

  • JH-X-119-01
  • JH-X-119-01 pictures
  • $60.00
  • 2026-05-11
  • CAS:2227368-54-7
  • Purity: 98.42%
  • Supply Ability: 10g
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Basic information
Product Name:2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
Synonyms:2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-;JH-X-119-01;N-(4-(3-Acrylamidobenzamido)phenyl)-6-(1H-pyrazol-3-yl)picolinamide;inhibit,MYD88,IRAK,IL-1R associated kinase,Waldenstr?m,Inhibitor,IRAK1,Interleukin-1 receptor associated kinase,JHX11901,Diffused Large B-cell Lymphoma,JH X 119 01,macroglobulinemia;JH-X-119-01, 10 mM in DMSO;JH-X-119-01 ，S9780
CAS:2227368-54-7
MF:C25H20N6O3
MW:452.46
EINECS:
Product Categories:
Mol File:2227368-54-7.mol
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Structure
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Chemical Properties
Boiling point 654.0±55.0 °C(Predicted)
density 1.405±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 250 mg/mL (552.54 mM; Need ultrasonic)
pka10.98±0.70(Predicted)
form Solid
color Light yellow to brown
Safety Information
MSDS Information
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Usage And Synthesis
UsesJH-X-119-01 is a potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 ameliorates LPS-induced sepsis in mice[1]. JH-X-119-01 inhibits IRAK1 biochemically with an apparent IC50 of 9 nM while exhibiting no inhibition of IRAK4 at concentrations up to 10 μM[2].
in vivo

JH-X-119-01 improves survival and decreases immunopathies of LPS-challenged mice. JH-X-119-01 increases survival of mice at the dose of 5 mg/kg body weight. Survival is further improved when the dose is increased to 10 mg/kg[1].

Animal Model:C57BL/6 (20-22 g, male) mice[1]
Dosage:5 mg/kg and 10 mg/kg
Administration:Intraperitoneally injected; 5 days
Result:Protected mice from LPS (20 mg/kg)-induced sepsis. Survival at day 5 was 13.3% in control group where septic mice were treated by vehicle, while the values were 37.5% and 56.3% for 5 mg/kg and 10 mg/kg.
IC 50IRAK-1: 9 nM (IC50)
References[1] Bin Pan, et al. Selective inhibition of interleukin-1 receptor-associated kinase 1 ameliorates lipopolysaccharide-induced sepsis in mice. Int Immunopharmacol. 2020 Aug;85:106597. DOI:10.1016/j.intimp.2020.106597
[2] John M Hatcher, et al. Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma. ACS Med Chem Lett. 2020 Oct 9;11(11):2238-2243. DOI:10.1021/acsmedchemlett.0c00378
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)- Preparation Products And Raw materials
Tag:2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-(2227368-54-7) Related Product Information